OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology
Michael H. Kagey, Xi He
British Journal of Pharmacology (2017) Vol. 174, Iss. 24, pp. 4637-4650
Open Access | Times Cited: 117
Michael H. Kagey, Xi He
British Journal of Pharmacology (2017) Vol. 174, Iss. 24, pp. 4637-4650
Open Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
Joseph Clara, Cecilia Monge, Yingzi Yang, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 4, pp. 204-232
Closed Access | Times Cited: 616
Joseph Clara, Cecilia Monge, Yingzi Yang, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 4, pp. 204-232
Closed Access | Times Cited: 616
Wnt–β-catenin signalling in liver development, health and disease
María J. Perugorria, Paula Olaizola, Ibone Labiano, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 2, pp. 121-136
Closed Access | Times Cited: 454
María J. Perugorria, Paula Olaizola, Ibone Labiano, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 2, pp. 121-136
Closed Access | Times Cited: 454
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 192
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 192
WNT Signaling in Melanoma
Anna Gajos-Michniewicz, Małgorzata Czyż
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4852-4852
Open Access | Times Cited: 173
Anna Gajos-Michniewicz, Małgorzata Czyż
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4852-4852
Open Access | Times Cited: 173
Primary cilia and ciliary signaling pathways in aging and age-related brain disorders
Rong Ma, Naseer A. Kutchy, Liang Chen, et al.
Neurobiology of Disease (2021) Vol. 163, pp. 105607-105607
Open Access | Times Cited: 75
Rong Ma, Naseer A. Kutchy, Liang Chen, et al.
Neurobiology of Disease (2021) Vol. 163, pp. 105607-105607
Open Access | Times Cited: 75
DKK1 Promotes Tumor Immune Evasion and Impedes Anti–PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer
Tao Shi, Yipeng Zhang, Yue Wang, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1506-1524
Open Access | Times Cited: 64
Tao Shi, Yipeng Zhang, Yue Wang, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1506-1524
Open Access | Times Cited: 64
Dickkopf-1: A Promising Target for Cancer Immunotherapy
Hang Yin Chu, Zihao Chen, Luyao Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 60
Hang Yin Chu, Zihao Chen, Luyao Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 60
Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients
Guohua Zhu, Jukun Song, Wei‐Min Chen, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 659-675
Open Access | Times Cited: 56
Guohua Zhu, Jukun Song, Wei‐Min Chen, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 659-675
Open Access | Times Cited: 56
Drug Discovery of DKK1 Inhibitors
Hewen Jiang, Zongkang Zhang, Yuanyuan Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Hewen Jiang, Zongkang Zhang, Yuanyuan Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 31
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 31
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
Satoshi Muto, Akio Enta, Yoshiyuki Maruya, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 190-190
Open Access | Times Cited: 27
Satoshi Muto, Akio Enta, Yoshiyuki Maruya, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 190-190
Open Access | Times Cited: 27
Dkk (Dickkopf) Proteins
Roberta Baetta, Cristina Banfi
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 7, pp. 1330-1342
Open Access | Times Cited: 72
Roberta Baetta, Cristina Banfi
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 7, pp. 1330-1342
Open Access | Times Cited: 72
The Yin and Yang of Myeloid Derived Suppressor Cells
Snehil Budhwar, Priyanka Verma, Rachna Verma, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 65
Snehil Budhwar, Priyanka Verma, Rachna Verma, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 65
A Review of the Role of Wnt in Cancer Immunomodulation
Whitney N. Goldsberry, Angelina I. Londoño, Troy D. Randall, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 771-771
Open Access | Times Cited: 56
Whitney N. Goldsberry, Angelina I. Londoño, Troy D. Randall, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 771-771
Open Access | Times Cited: 56
mDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment
Michael Haas, Michael H. Kagey, Heidi Heath, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 4, pp. 717-725
Open Access | Times Cited: 55
Michael Haas, Michael H. Kagey, Heidi Heath, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 4, pp. 717-725
Open Access | Times Cited: 55
Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
Ilaria Betella, William J. Turbitt, Tomasz Szul, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 3, pp. 765-774
Closed Access | Times Cited: 53
Ilaria Betella, William J. Turbitt, Tomasz Szul, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 3, pp. 765-774
Closed Access | Times Cited: 53
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Lipika Goyal, Cynthia A. Sirard, Michael Schrag, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 23, pp. 6158-6167
Open Access | Times Cited: 52
Lipika Goyal, Cynthia A. Sirard, Michael Schrag, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 23, pp. 6158-6167
Open Access | Times Cited: 52
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
David R. Wise, Jeffrey A. Schneider, Joshua Armenia, et al.
JCO Precision Oncology (2020), Iss. 4, pp. 1167-1179
Open Access | Times Cited: 51
David R. Wise, Jeffrey A. Schneider, Joshua Armenia, et al.
JCO Precision Oncology (2020), Iss. 4, pp. 1167-1179
Open Access | Times Cited: 51
The anti-DKK1 antibody DKN-01 as an immunomodulatory combination partner for the treatment of cancer
Jaclyn Wall, Samuel J. Klempner, Rebecca C. Arend
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 7, pp. 639-644
Closed Access | Times Cited: 50
Jaclyn Wall, Samuel J. Klempner, Rebecca C. Arend
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 7, pp. 639-644
Closed Access | Times Cited: 50
Dickkopf signaling, beyond Wnt-mediated biology
Akira Kikuchi, Shinji Matsumoto, Ryota Sada
Seminars in Cell and Developmental Biology (2021) Vol. 125, pp. 55-65
Open Access | Times Cited: 41
Akira Kikuchi, Shinji Matsumoto, Ryota Sada
Seminars in Cell and Developmental Biology (2021) Vol. 125, pp. 55-65
Open Access | Times Cited: 41
Modulation of Wnt–β-catenin signaling with antibodies: therapeutic opportunities and challenges
Siobhan O’Brien, Rony Chidiac, Stéphane Angers
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 354-365
Closed Access | Times Cited: 20
Siobhan O’Brien, Rony Chidiac, Stéphane Angers
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 354-365
Closed Access | Times Cited: 20
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 7
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 7
Wnt signalling pathways in chronic lymphocytic leukaemia and B‐cell lymphomas
Pavlína Janovská, Vı́tězslav Bryja
British Journal of Pharmacology (2017) Vol. 174, Iss. 24, pp. 4701-4715
Open Access | Times Cited: 55
Pavlína Janovská, Vı́tězslav Bryja
British Journal of Pharmacology (2017) Vol. 174, Iss. 24, pp. 4701-4715
Open Access | Times Cited: 55
ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway
Peng Zeng, Jie Yang, Lipei Liu, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1129-1146
Open Access | Times Cited: 49
Peng Zeng, Jie Yang, Lipei Liu, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1129-1146
Open Access | Times Cited: 49
